Background: The aim of this study was to compare the utility and diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) in the diagnosis of Alzheimer's disease (AD) and mild cognitive impairment (MCI) in a clinical cohort. Methods: Three hundred twenty-one AD, 126 MCI, and 140 older adults with healthy cognition (HC) were evaluated using the MMSE, the MoCA, a standardized neuropsychologic battery according to the Consortium to Establish a Registry of Alzheimer's Disease (CERAD-NB), and an informant-based measure of functional impairment, the Dementia Severity Rating Scale (DSRS). Diagnostic accuracy and optimal cut-off scores were calculated for each measure, and a method for converting MoCA to MMSE scores is presented.
Introduction
Alzheimer's disease (AD) is a chronic, debilitating condition causing significant disease burden and mortality in adults .65 years of age [1] [2] [3] [4] . The health and economic impact of AD has led to a pressing need to prevent or slow disease onset and progression, and recent research efforts have focused on the transitional period from normal cognitive aging to dementia [5] . This transition period, typically associated with mild cognitive impairment (MCI), is signified by a measurable deterioration in cognitive function that is greater than expected based on an individual's age and education but which has not meaningfully affected a person's daily functioning [6] . Despite its being a major research focus in recent years [7] , establishing the diagnosis of MCI with standard neuropsychologic assessment instruments has remained challenging [8] .
In the absence of MCI screening measures with established cut-off scores and confidence intervals, more extensive neuropsychologic testing is often advised to reliably differentiate MCI from healthy cognitive aging (HC) or AD, although professional availability, time, and cost often do not allow this to occur. An efficient battery used at many specialized memory clinics and Alzheimer's disease research centers is the Consortium to Establish a Registry for Alzheimer's neuropsychologic battery (CERAD-NB) [9] [10] [11] [12] [13] . Although this battery was developed specifically for AD, it also has been used to discriminate between MCI and HC with some success [12] [13] [14] . The latter battery is briefer than standard neuropsychologic batteries, but the CERAD-NB is still lengthy and requires specialized training for proper administration, which makes it less practical for use in the typical neurology or geriatric practices. Thus, brief, validated, practical measures that can differentiate MCI and dementia would be very useful given the increase in the proportion of elderly individuals seeking medical help for memory-related changes.
Brief screening measures, such as the Mini-Mental State Examination (MMSE) [15] and Montreal Cognitive Assessment (MoCA) [16] , are easily administered with little training and have demonstrated diagnostic utility [17, 18] , particularly in differentiating dementia from normal cognitive aging [19, 20] . Recently, the diagnostic accuracy of these two screening measures has received increased attention as the importance of differentiating AD and MCI has grown [17, 21] . Both the MMSE and MoCA accurately differentiate cognitive impairment (MCI or AD) from normal cognitive aging [20] , but the MoCA has shown more utility in other disorders (e.g., Parkinson's disease [22] ). To our knowledge, only one study has directly compared the MoCA and the MMSE in differentiating MCI from AD and healthy aging in a large clinical cohort [19] and one study examined MCI subtypes [23] . The latter study, which included AD patients, found improved accuracy for the MoCA, but the study was limited to the amnestic subtype of MCI in a Portuguese sample. There is a dearth of research comparing the diagnostic accuracy of the MoCA to other standardized measures in a well-characterized clinical dementia cohort. Furthermore, if the MoCA is a more accurate screening measure for MCI, as shown in other neurologic disorders [24, 25] , then a straightforward conversion of MoCA to MMSE scores would be useful given the vast amount of clinical and research that has been collected using the MMSE.
It is doubtful that brief cognitive screening instruments alone would be sufficient to accurately distinguish mild dementia from MCI. Such a distinction is made when cognitive decline is, by definition, associated with meaningful decline in daily personal, social, or occupational functioning [26] [27] [28] . Such functional decline may not be reported by the patient and requires report from a family member or other informant. There are many observer-based functional rating scales that together with a brief cognitive measure may significantly improve diagnostic accuracy [29] [30] [31] [32] [33] [34] [35] .
The aims of this study were to: (1) compare the diagnostic accuracy of the MMSE and MoCA to a more detailed assessment of neuropsychologic performance (the CERAD-NB); (2) measure the improvement in diagnostic accuracy when the MMSE or MoCA were used in combination with a measure of functional impairment (Dementia Severity Rating Scale [35] ); and (3) determine a simple and reliable algorithm for conversion of MoCA to MMSE scores in diagnosis of AD and MCI in a large, well-characterized communitydwelling cohort evaluated and diagnosed by clinicians at a specialized memory center.
Methods

Study population
All participants were recruited from the Penn Memory Center and Clinical Core of the University of Pennsylvania's Alzheimer's Disease Center. Participants included 321 individuals with clinical consensus diagnoses of AD, 126 individuals with MCI, and 140 HC adults (Table 1) . Diagnostic assessments included history and physical and neurologic examinations conducted by experienced clinicians, including the review of neuroimaging, psychometric, and laboratory data. On the basis of all these data, a consensus diagnosis was established using standardized clinical criteria for AD, MCI, or other neurologic or psychiatric conditions presenting with cognitive impairment [5, 6, 26, 36] . Screening and cognitive assessments included the MMSE, the MoCA, and the CERAD-NB. A composite score for the CERAD battery was derived using a method described by Chandler et al [12] . We used the method from their study that excluded the MMSE from the CERAD composite total score, and also provided age-, education-, and gendercorrected scores [12] . The MoCA was administered on the same day as the clinical and neuropsychologic evaluation. In addition, the Dementia Severity Rating Scale (DSRS) was administered to assess functional capacity. The DSRS is a reliable, simple, 12-item, multiple-choice questionnaire that collects information from a knowledgeable informant on impairment severity in 12 cognitive and functional domains [37] . The MMSE, CERAD-NB, and DSRS were available during consensus diagnosis, but the MoCA was not. MCI subtypes and dementias other than AD were not analyzed in this study. HC subjects were also recruited and assessed identically to the patients with AD and MCI. Informed consent for the use of all data was obtained from all persons, in accord with university institutional review board-approved protocols. All participants completed the MMSE and MoCA. Most, but not all, participants completed the CERAD-NB and DSRS. Most participants were also given the Geriatric Depression Scale (GDS) as a screening measure for mood disturbances [38] (see Table 1 ).
Statistical analysis
Demographic characteristics were compared across diagnostic groups using Pearson c 2 or one-way analyses of variance (ANOVAs) with post hoc t-tests. The diagnosis accuracy for each measure (or combination of measures) was calculated as the area under the receiver-operating characteristic (ROC) curve (AUC). The AUC measure represents the mean sensitivity value for all possible values of specificity. A cut-off score for each measure that best differentiated diagnostic groups was determined using the Youden index [39] , which maximizes the trade-offs between sensitivity [12] ).
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MoCA scores were equated to MMSE scores using the equipercentile equating method [40] . Equipercentile equating has been used to equate numerous standardized tests, including equating of the Telephone Interview for Cognitive Status (TICS) scores to MMSE scores in older adults [41] . This statistical method allows for the determination of comparable test scores from two different measures on the basis of their corresponding percentile ranks. The advantage of the equipercentile equating method is that the equated scores always fall within the range of possible scores, which is not always true when using traditional mean and linear equating methods. However, this method can lead to an irregular distribution of scores, and thus a log-linear transformation [42] was used to smooth the raw scores of MoCA and MMSE into a regular distribution. Equipercentile equating and log-linear smoothing was performed using the "equate" library in the R statistical program [43] [44] [45] [46] .
Results
Demographic characteristics along with significance values are presented in Table 1 . The diagnostic groups differed in age, education, and gender distribution, but not race or ethnicity. The groups differed in GDS score [F(2, 536) 5 30.14, P , .01], with the AD group reporting the highest score on this measure, followed by the MCI group and the NC group. GDS mean scores were, however, ,5 for all three groups and for the majority of individual participants, suggesting that no subject suffered from clinically significant depression (Table 1 ). The AD group performed significantly poorer than the MCI and HC groups on each task; the MCI group performed significantly poorer on each cognitive task than the HC group (Table 1) . For all participants, age was weakly, but significantly, correlated with each screening and cognitive measure: age and MMSE (r 5 20.19, P , .001, n 5 587); age and MoCA (r 5 20.20, P , .001, n 5 587); age and CERAD-NB (r 5 20.25, P , .001, n 5 534); and age and DSRS (r 5 0.23, P , .001, n 5 579).
ROC analysis of standard screening measures: A comparison of CERAD-NB, MMSE, and MoCA
The ROC curve analysis was used to evaluate the diagnostic accuracy of each measure (CERAD-NB, MMSE, and MoCA) to discriminate AD and MCI from one another and from healthy cognitive aging. Graphic representations of the ROC curves are provided in Figure 1 . A cut-off score of 83 on the adjusted CERAD-NB, 28 on the MMSE, and 23 on the MoCA yielded the highest Youden index for discriminating between HC and AD ( Table 2 , part A). The classification accuracy of a score of 83 on the CERAD-NB was nominally better at classifying healthy and AD individuals than the optimal MoCA score (Z 5 1.71, P 5 .08) and significantly better than the optimal MMSE score (Z 5 2.53, P 5 .01). The classification accuracy of the MMSE and MoCA were comparable (Z 5 1.33, P 5 .18).
HC vs MCI
A cut-off score of 89 on the CERAD-NB, 29 on the MMSE, and 25 on the MoCA yielded the highest Youden index for discriminating between HC and MCI ( Table 2 , part A). The classification accuracy of the optimal CERAD-NB score was better at classifying healthy and AD individuals than either the optimal MMSE (Z 5 5.74, P , .001) or MoCA (Z 5 2.94, P , .01) score. Classification accuracy of the MoCA was superior to the MMSE (Z 5 3.56, P , .001).
AD vs MCI
A cut-off score of 69 on the CERAD-NB, 25 on the MMSE, and 19 on the MoCA yielded the highest Youden index for discriminating between AD and MCI ( Table 2 , part A). The classification accuracy of the cut-off score was equally good for the CERAD-NB, the MMSE, and the MoCA.
ROC analysis of informant-based measure: The DSRS
Area under the ROC curve, the optimal cut-off score, sensitivity, specificity, and classification accuracy for the DSRS are presented in 
Cut-off scores: The DSRS
A cut-off score of ,3 on the DSRS yielded the highest Youden index for discriminating between HC and AD, a score of 2 was best for discriminating HC and MCI, and a score of 10 best differentiated AD from MCI. When discriminating between HC and AD or HC and MCI the DSRS yielded higher classification accuracy than the MMSE [HC vs AD: Z 5 3.89, P , .001; HC vs MCI: Z 5 5.90, P , .001] or MoCA [HC vs AD: Z 5 3.02, P , .01; HC vs MCI: Z 5 3.56, P , .001]. In contrast, the DSRS was poorer than the MMSE [Z 5 2.25, P 5 .03] and nominally poorer than the MoCA [Z 5 1.84, P 5 .07], but equally as accurate as the CERAD-NB when discriminating MCI and AD (Table 2 , part B).
ROC analysis of combining an informant-based measure with cognitive screening tasks
Combining the DSRS with the MMSE or MoCA significantly improved diagnostic accuracy as compared with using either screening measure alone ( 512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578   579  580  581  582  583  584  585  586  587  588  589  590 Using the combination of optimal cut-off scores of the MoCA and/or DSRS to classify individuals resulted in an increase of 17% for HC and MCI and 13% for MCI and AD. Changes in diagnostic accuracy were not assessed for HC vs AD, as diagnostic accuracy of each test alone was already excellent (.0.99).
Equating MMSE and MoCA scores
The plot of equipercentile equivalent scores on the MMSE and MoCA is presented in Figure 2 . As an example, Figure 2 indicates that a score of 18 on the MoCA is equivalent to a score of 24 on the MMSE, with both of these scores falling at approximately the 50th percentile within a clinical sample with a wide range of cognitive impairment. Table 4 shows scores on the MoCA and their respective equivalents on the MMSE. In general, lower MoCA scores are equal to higher MMSE scores. For example, scores of 28-30 on the MoCA are equivalent to the highest score of 30 on the MMSE.
Discussion
Overall, our findings in a relatively large, communitydwelling cohort, evaluated at a specialty memory clinic, suggest that the individual screening measures (MMSE and MoCA) typically used in clinical practice to aid in the diagnosis of AD or MCI offer reasonably high classification and diagnostic accuracy when compared with a more detailed neuropsychologic evaluation (CERAD-NB). However, as a brief, stand-alone cognitive screening measure, the MoCA appears to be more sensitive than the older, but more widely used MMSE. Furthermore, using the optimal cut-off score, the classification accuracy of the MoCA exceeded that of the MMSE when differentiating MCI from HC. This finding is consistent with a recent study showing that the MoCA is more sensitive than the MMSE at detecting patients with mild cognitive impairment in Parkinson's disease (PD) from those with a diagnosis of PD alone. In addition, using an informant-based questionnaire of functional impairment (the DSRS) resulted in comparable, or higher, overall diagnostic accuracy for most comparisons. However, accurately differentiating MCI from AD proved the most difficult, regardless of the measure used. Finally, we have provided a simple, yet reliable, method for equating MoCA scores to traditional MMSE scores.
Our results confirm and extend prior findings on the diagnostic utility of cognitive tests in AD and MCI. First, we found that an efficient but multidimensional neuropsychologic inventory, the CERAD-NB, is more accurate at distinguishing MCI or AD from healthy individuals than brief screening measures, but not more accurate than the MMSE or MoCA at differentiating AD from MCI. The diagnostic accuracy of the CERAD-NB (93%) when differentiating MCI from the HC group in our study was very similar to that in a recent, multinational study of the diagnostic accuracy of the total CERAD score [13] . Better diagnostic accuracy using the CERAD-NB is expected as it is more web 4C=FPO web 4C=FPO Fig. 2 . Corresponding raw scores and raw percentile ranks for the MMSE and MoCA. As an example, a score of 18 on the MoCA is equivalent to a score of 24 on the MMSE. 10  16  11  17  12  19  13  20  14  21  15  22  16  22  17  23  18  24  19  25  20  26  21  26  22  27  23  28  24  28  25  29  26  29  27  29  28  30  29  30  30  30 *Equivalent scores were derived from equipercentile equating with loglinear smoothing.
comprehensive, encompasses multiple cognitive domains, and is highly correlated with the MMSE and MoCA [12] . Thus, it can serve as a reliable standard to which the MMSE and MoCA can be compared.
We have extended upon previous findings [19, 20, 47, 48 ] that the MoCA is a superior screen than the MMSE for detecting AD and MCI. Both measures easily identified AD compared with HC and were comparable with the CERAD-NB. More striking was the accuracy of the MoCA at differentiating MCI from HC as compared with the MMSE. These data suggest that the MoCA may be more sensitive to early changes in cognitive ability as it includes more robust measures of visuospatial and executive function [16] . Diagnostic accuracy declined when using these instruments to distinguish between AD and MCI. Although we found that the MMSE and MoCA were comparably accurate in differentiating AD from MCI, and the accuracy of both screens was similar to the CERAD-NB, this transition in clinical status remains a challenge for psychometric instruments. In particular, difficulty in differentiating AD from MCI is likely due to several factors including, but not limited to: (1) the heterogeneity of the MCI diagnosis; (2) the progression rates of MCI to AD of 10%-15%/year [5] ; (3) limited research that has focused on cross-sectional differentiation of MCI from AD and healthy older adults (see Lonie et al [8] ); and (4) the relative dearth of MCI-specific screening measures. The importance of this last point cannot be understated as the real clinical value of any test will be in its prediction of further decline, and its relationship with disease-specific biomarkers that lead to significantly improved diagnostic accuracy.
We extend upon previous findings by assessing the diagnostic accuracy of the DSRS, an informant-based measure of functional impairment. Notably, the DSRS provided better classification accuracy than the MMSE or MOCA, and comparable accuracy to the CERAD-NB, for AD and MCI when compared with HC. Yet, the diagnostic and classification accuracy of the DSRS fell, like the other measures, when differentiating AD from MCI. The DSRS may provide additional insight into the functional levels of disease severity or subtypes of MCI, especially in the absence of overt dementia. Given the capability of the DSRS to correctly discriminate dementia from healthy cognitive aging, we found that combining this measure with either the MMSE or MoCA increased diagnostic accuracy. This increase is of note as the DSRS is a reliable tool for indicating the severity of AD throughout the course of the disease [37] . Furthermore, the DSRS, unlike many cognitive measures, changes at a steady and predictable rate [35] , making it an ideal measure to monitor changes in the disease course, and may provide a useful metric to measure response to treatment. Previous studies showed that combining cognitive and informant-based screens (e.g., Informant Questionnaire on Cognitive Decline in the Elderly) improved diagnostic accuracy [30, 31] , suggesting that measures of instrumental activities of daily living be incorporated into the diagnostic criteria for MCI [49] . To our knowledge, the present study is the first to combine the DSRS with other screening measures to differentiate AD from MCI from HC. Given these results, further studies should consider including the DSRS during diagnostic assessment.
Finally, we used equipercentile equating to develop a conversion score between the MoCA and MMSE. Herein we have provided a table of conversion scores enables the widely recognized cut-off scores on the MMSE to be reliably compared with scores on the MoCA. Although the MMSE is the most commonly used clinical screen for monitoring acute or declining cognitive impairment, it has several limitations, such as marked ceiling effects in younger, well-educated individuals, and inconsistent performance in differentiating MCI from healthy older adults, as many individuals with MCI score above the recommended MMSE cutoff (score of 26) for impairment (for review, see Lonie et al [8] ). Thus, the MMSE has limited utility in detecting subtle changes in cognition that may signal pending impairment [50, 51] . The MoCA does not overcome all of the shortcomings of the MMSE, but recent data, including ours, indicate that the MoCA is a superior screening measure for classifying MCI. Equating scores on these two measures provides a straightforward way of comparing the MoCA to the MMSE, thus allowing for continuity of cognitive tracking in the clinic and comparability of data in longitudinal studies of MCI or dementing illness.
Our use of a large, well-characterized, community-dwelling cohort provides a useful perspective for determining the diagnostic accuracy of standardized global screening measures in AD and MCI. However, our study is not without limitations. The differences in gender distribution across the groups present challenges in interpreting the results. As expected, there were more women diagnosed with AD than men [52] ; however, the gender distribution within the MCI group was essentially a 50/50 split. It is possible the men are overrepresented in the group due to other factors. A comparison of gender-specific diagnostic accuracy was beyond the scope of this study, but should be examined in future investigations. The impact of comorbid clinical factors, such as depression, were not considered in this study but could impact the utility of some screening measures; however, the MoCA appears robust to depression symptoms within healthy cohorts [53] , and in the current sample self-reported rates of depression were low. The sample was well-educated, particularly the healthy cognition group, which makes generalization to less well-educated cohorts more challenging as education does impact MMSE [8] and MoCA [53] performance. Overall, the sample size of this study was adequate, but more precise cut-off values for each diagnostic test could be achieved with an increase in the number of MCI patients. An increase in number and subtypes of MCI, which was not considered in this study, would provide more specificity and may lead to improved diagnostic accuracy and utility. Because the MoCA shows a wider range of performances in AD and MCI than the MMSE, it seems likely that the MoCA can be used to determine differing levels of severity or subtypes of MCI. This is particularly important as the diagnosis of MCI or AD increases with age, and thus performance on the MMSE or MoCA may systematically differ in an 80-year-old MCI patient when compared with a 60-year-old MCI patient. Thus, future studies should consider age-and domain-specific performance cut-offs.
The aim of this investigation was to compare individuals with a known diagnosis of AD or MCI to a healthy comparison group in a specialty memory and aging clinic. As a result, generalizing to other clinical settings should be done with caution. Given that the clinicians were not blinded to the MMSE, CERAD-NB, and DSRS during consensus diagnosis it is possible that diagnostic decisions were influenced by the availability of these measures. However, there was no systematic rubric employed at consensus and the data do not suggest that one or more of these measures were used preferentially to achieve diagnosis. Given the paucity of screening tools that are specific to differentiating MCI from AD and normal cognitive aging, we believe that the findings presented herein offer useful information about well-utilized standardized metrics and their diagnostic effectiveness.
In conclusion, our results support recent data that the MoCA is superior to the MMSE as a global assessment tool and we have described a reliable method for comparing the two screening measures. Furthermore, we found that when these traditional screening measures are used in the diagnosis of AD and MCI with complementary informantbased ratings of functional impairment, overall diagnostic accuracy improves . 914  915  916  917  918  919  920  921  922  923  924  925  926  927  928  929  930  931  932  933  934  935  936  937  938  939  940  941  942  943  944  945  946  947  948  949  950  951  952  953  954  955  956  957  958  959  960  961  962  963  964  965  966  967  968  969  970  971  972  973 
